| COMPOSITION: | Each tablet contains Cabergoline 0.5 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Caberford 0.25 tablets contain Cabergoline, a Dopaminergic receptor agonist that exerts direct inhibitory effect on Prolactin secretion. Caberford inhibits excessive secretion of Prolactin and thus improves associated complications of Infertility, menstrual irregularity, breast enlargement. Caberford is indicated in the treatment of abnormal secretion of breast milk, Hyperprolactinemia and its complications. |
| SIDE EFFECTS: | Dizziness, bloating, cold sweats & tingling on the hands & feet. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
